Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Eeles

Showing results (61-70 of 110) with videos related to

Pageof 11
Sort By:
British Journal of Cancer|April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer|April 16, 2002
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohortC Foster, D G R Evans, R Eeles, et al.
British Journal of Cancer|October 27, 2004
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohortM Watson, C Foster, R Eeles, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
British Journal of Cancer|February 3, 2005
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effectsD P Dearnaley, E Hall, D Lawrence, et al.
British Journal of Cancer|February 8, 2007
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-upC Foster, M Watson, R Eeles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2017
Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate CancerA Patrikidou, M Uccello, A Tree, et al.
British Journal of Cancer|May 27, 2016
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
Nature Genetics|September 1, 1994
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusA Kamb, D Shattuck-Eidens, R Eeles, et al.
Journal of Medical Imaging and Radiation Oncology|July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancerR Venkitaraman, G J R Cook, D P Dearnaley, et al.
Pageof 11

Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
British Journal of Cancer|April 22, 2015
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
British Journal of Cancer|April 16, 2002
Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohortC Foster, D G R Evans, R Eeles, et al.
British Journal of Cancer|October 27, 2004
Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohortM Watson, C Foster, R Eeles, et al.
The American Journal of Pathology|May 1, 1995
Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppressionN A Gruis, J Weaver-Feldhaus, Q Liu, et al.
British Journal of Cancer|February 3, 2005
Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effectsD P Dearnaley, E Hall, D Lawrence, et al.
British Journal of Cancer|February 8, 2007
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-upC Foster, M Watson, R Eeles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 28, 2017
Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate CancerA Patrikidou, M Uccello, A Tree, et al.
British Journal of Cancer|May 27, 2016
Selective organ preservation with neo-adjuvant chemotherapy for the treatment of muscle invasive transitional cell carcinoma of the bladderS Hafeez, A Horwich, O Omar, et al.
Nature Genetics|September 1, 1994
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locusA Kamb, D Shattuck-Eidens, R Eeles, et al.
Journal of Medical Imaging and Radiation Oncology|July 24, 2009
Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancerR Venkitaraman, G J R Cook, D P Dearnaley, et al.
Pageof 11